How many patents does
Dynavax Technologies Corporation have?
patents
321
families
39
granted
84
applications
237
US
83
EP
46
WO
24
JP
16
CN
13
KR
9
RoW
130
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Dynavax Technologies Corporation
Top ten assignees appearing on patents
2009 - 2018
| dynavax technologies corporation | 274 |
| merck & company | 14 |
| matray, tracy | 8 |
| dynavax tech corporation | 5 |
| astrazeneca | 1 |
| astrazeneca uk | 1 |
Dynavax Technologies Corporation
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| immunostimulatory sequence oligonucleotides and methods of using the same | 33 | 2002 |
| chimeric immunomodulatory compounds and methods of using the same | 23 | 2001 |
| intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treati… 🛈 | 23 | 2015 |
| methods of treatment using tlr7 and/or tlr9 inhibitors | 23 | 2010 |
| methods and compositions for inhibition of innate immune responses and autoimmunity | 19 | 2004 |
| methods and compositions for inhibition of immune responses and autoimmunity | 15 | 2007 |
| human toll-like receptor inhibitors and methods of use thereof | 14 | 2012 |
| inhibitors of dna immunostimulatory sequence activity | 14 | 1997 |
| long term disease modification using immunostimulatory oligonucleotides | 14 | 2006 |
| long term disease modification using immunostimulatory oligonucleotides | 13 | 2008 |